Predominance of customary risk factors in myocardial infarction patients of different age groups at tertiary health care hospital, Lahore, Pakistan
Bauman A, Alharbi M, Lowres N, Gallagher R, Stamatakis E, Vasan RSD. 2017. Exercise, physical activity, and cardiovascular disease. The Encyclopedia of Cardiovascular Research and Medicine. Elsevier Oxford 274-280.
Buford TW. 2016. Hypertension and Aging. Ageing Res Rev 26, 96-111.
Cífkova R, Skodová Z, Bruthans J. 2010. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. Atherosclerosis 211(2), 676-81.
Clark H. 2013. NCDs: a challenge to sustainable human development. Lancet 381 (9866), 510-511.
David Carrick D, Haig C, Maznyczka AM. 2018. Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction. Hypertension 72(3), 720-730.
Devi P, Rao M, Sigamani A. 2013. Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens 27(5), 281-287.
Egan BM, Zhao Y, Axon RN. 2010. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303, 2043-2050.
Ekelund E, Steene-Johannessen J, Brown WJ. 2016. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet 388(10051), 1302-1310.
GBD. Risk Factors Collaborators. 2013. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risk factors or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2013.
Grundy SM, Benjamin IJ, Burke GL. 1999. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American heart association. Circulation 100(10), 1134-1146.
Huxley R, Barzi F, Woodward M. 2006. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332(7533), 73-78.
John RP, Tomasz JG, Rhian MT. 2018. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology 34(5), 575e-584.
Katherine T, Mills KT, Bundy JD, Kelly TN. 2016. Global Disparities of hypertension Prevalence and control a systematic analysis of Population-Based studies From 90 countries. Circulation 134, 441-45.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. 2005. Global burden of hypertension: analysis of worldwide data. Lancet 365(9455), 217-23.
Kira G, Franziska S, Patrick S, Gabriele IS, Christine D, Winfried M. 2019. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. European Journal of Epidemiology 34(1), 37-55.
Lancet. 2010. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies 375(9733), 2215-2222.
Lanclet Global Health. 2018. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016. Lancet 6(12), e1339-e1351.
Lara H, Martijn S, Van R, Joanne U, Maria P, Irene GMV. 2018. Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis. BMC Public Health 18, 276.
Lawes CM, Vander Hoorn S, Rodgers A. 2008. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 371(9623), 1513-8.
Lloyd-Jones DM, Nam BH, D’Agostino SR. 2004. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. AMA 291(18), 2204-11.
Murabito JM, Pencina MJ, Nam BH. 2005. Sibling Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults. JAMA 294(24), 3117-3123.
Ogurtsovaa K, da Rocha Fernandesa JD, Huanga Y, et al. 2017. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128, 40-50.
Petrie JR, Guzik TJ, Touyz RM. 2018. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol 34(5), 575-584.
Ralston J, Reddy KS, Fuster V, Narula J. 2016. Cardiovascular diseases on the global agenda: the United Nations high level meeting, Sustainable Development Goals, and the way forward. Glob Heart 11(4), 375-379.
Ravi D, Ramachandran SV. 2011. Age as a Cardiovascular Risk Factor. Med Clin North Am 96(1), 87-91.
Rawshani A, Rawshani A, Franzén S, Sattar N. 2018. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. The new England journal of medicine 379(7), 633-644.
Schramm TK, Gislason GH, Kober L. 2008. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117(15), 1945-1954.
Spencer EA, Pirie KL, Stevens RJ. 2008. Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol 23(12), 793-799.
Stamatakis E, Gale J, Bauman A, Ekelund U, Hamer M, Ding D. 2019. Sitting Time, Physical Activity, and Risk of Mortality in Adults. Journal of the American College of Cardiology 73(16), 2062 – 7 2.
Stevens RJ, Kothari V, Adler AI, Stratton IM. 2001. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci Lond 101(6), 671-679.
Valerio L, Ron JP, Aeilko HZ, Winderman, Sara‐Joan P. 2016. Association of Family History with Cardiovascular Disease in Hypertensive Individuals in a Multiethnic Population. J Am Heart Assoc 5(12) DOI: 10.1161.
Vasan RS, Sullivan LM, Wilson PW. 2005. Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors. Ann Intern Med 142(6), 393-41.
WHO. 2013. Global action plan for the prevention and control of no communicable diseases: 2013-2020. Resolution WHA 66.10.
World Health Organization. 2003. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation WHO. 916.
World Health Organization. 2014. Global status report on no communicable diseases 2014: attaining the nine global no communicable diseases targets; a shared responsibility. World Health Organization Geneva.
Young DR, Hivert MF, Alhassan S. 2016. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation 134, e262-e279.
Yusuf S, Hawken S, Ounpuu S. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the Interheart study). Lancet 364(9438), 937-52.
Yusuf S, Rangarajan S, Teo K. 2014. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 371(9), 818-827.